Clin2
NCT07362914Possibly a fitRecruiting

Steroid cream for hand-foot skin reactions from chemo

Breast Cancer

Treatments studied

Part of Cancer, Skin clinical trials.

This trial tests whether a corticosteroid cream can prevent or reduce hand-foot skin reactions caused by liposomal doxorubicin (a type of chemotherapy) in breast cancer patients. If you are starting this chemo and are concerned about skin side effects, this study may offer a way to manage them.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
182 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You are between 18 and 70 years old.
  • You have breast cancer (early or advanced) confirmed by a biopsy.
  • You are scheduled to receive a chemo regimen that includes liposomal doxorubicin and cyclophosphamide.
  • You are in good general health (able to do daily activities without much help) and have adequate organ function (kidneys, liver, blood counts).
  • You have not had liposomal doxorubicin before and are not allergic to doxorubicin or similar products.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05341141Recruiting
Cold therapy plus compression to prevent nerve damage from chemo

This trial tests whether using cold therapy (cryotherapy) together with compression can lower the chance of numbness, tingling, or pain in the hands and feet caused by chemotherapy. It may help people planning chemotherapy for breast cancer stay more comfortable and function better.

Beijing, Beijing Municipality
NCT06905561Recruiting
Diclofenac cream to prevent skin irritation from radiation

This trial tests if a diclofenac cream can help prevent skin redness, peeling, or pain caused by radiation therapy. It is for people with certain head and neck cancers or breast cancer who are starting radiation treatment.

Haikou, Hainan
NCT06639178Recruiting
Cream to prevent hand-foot syndrome from capecitabine in breast cancer

This trial tests whether a special cream containing N-acetylcysteine and urea can prevent the painful hand-foot syndrome often caused by the chemotherapy drug capecitabine. If you have breast cancer and are about to start capecitabine, this study may help reduce side effects.

Aviano, Pordenone
NCT07137793Recruiting· Phase 2
Pentoxifylline to protect the heart during breast cancer chemo

This trial tests if a medicine called pentoxifylline can help prevent heart damage caused by doxorubicin, a common chemotherapy drug for breast cancer. If you are starting doxorubicin for the first time, this study may offer added heart protection.

Damanhūr
NCT07377279Recruiting
Acupuncture and compression to prevent nerve pain from chemo

This trial tests whether acupuncture and compression therapy can prevent nerve damage caused by taxane chemotherapy in early-stage breast cancer. It aims to reduce numbness, tingling, or pain in the hands and feet.

Guangzhou, Guangdong
NCT06642441Recruiting
Vitamin D for reducing chemotherapy side effects in breast cancer

This trial tests whether taking vitamin D supplements can reduce side effects from chemotherapy in people with breast cancer. It is for patients with low vitamin D levels who are about to start their first chemotherapy treatment.

Xining, Qinghai

Hear when a new Breast cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.